Discover technology-enabled solutions that generate impactful evidence with speed.

Real world evidence (RWE) is increasingly being used across the product lifecycle, shaping trial strategy and design, influencing regulatory decision making, and demonstrating commercial differentiation and drug value.

• Maximizing value from RWE generation with an Integrated Evidence Strategy that supports end-to-end, multi-stakeholder needs
• Incorporating patient centricity as a true strategic catalyst
• Leveraging the latest technologies and direct-to-patient innovations to enable faster, more efficient evidence generation for real world studies
• How technology-enabled analytics, natural language processing, and AI/ML can better inform decision making

• Session 1, April 21^st: How integrated RWE generation and patient-centered strategies maximize RWE impact
• Session 2, April 22^nd: Evidence generation approaches: Faster, fit-for-purpose real world studies with primary and secondary data
• Session 3, April 27^th: Unlocking the value of real world data with Natural Language Processing and Artificial Intelligence
• Session 4, May 5^th: Game-changing evidence approaches: Lessons from COVID for life sciences and beyond

Feature speakers

	Nancy Dreyer Senior Vice President and Chief Scientific Officer, Real World Solutions
	Kris Gustafson Vice President and Global Head, Patient Centered Technologies
	Jean Paty Vice President, Patient Centered Endpoints